Recently diagnosed with thyroid eye disease? You may want to know about a new clinical study

December 09, 2024 at 06:01 AM EST

(BPT) - Your eyes can tell you a lot about your health, and this is especially true for those living with thyroid eye disease (TED). TED occurs when the immune system mistakenly targets the tissues around the eyes, leading to symptoms like swelling, bulging and discomfort. During the active phase of TED, when these symptoms are most pronounced, people often experience redness, pain, and inflammation, which can impact daily life.

TED is commonly associated with Graves' disease, an autoimmune condition where the immune system attacks the thyroid gland. According to the American Thyroid Association, TED can manifest symptoms such as a gritty sensation in the eyes, light sensitivity, dry eyes, and even double vision. While these symptoms may vary in intensity and can improve over time, some individuals may experience more severe forms that require prescription medication or, in some situations, surgery.

A new investigational drug

In an effort to develop additional drug options for TED, researchers are conducting a clinical trial called the spiriTED study. This study is focused on evaluating an investigational drug, TOUR006, in adults with Graves' disease whose onset of TED symptoms began in the past 15 months. The goal is to better understand how TOUR006 may work in comparison to a placebo - a substance without any active investigational drug.

How to participate in the spiriTED study

Current treatments for conditions like TED exist thanks to the participation of research study volunteers. If you or someone you know is managing moderate to severe active-phase TED, you might consider joining the spiriTED study to help advance research efforts for yourself and others facing similar challenges.

To be eligible, participants must be between 18 and 80 years old, have been diagnosed with Graves' disease and are currently experiencing moderate to severe symptoms of TED that began in the last 15 months. Note that this is not a complete list of study eligibility requirements. The study doctor will review the full requirements for this study with you. You may be eligible for reasonable compensation for your time to attend study visits and/or reimbursement for certain approved study-related costs, such as transportation. Your safety is a top priority, and you'll be monitored throughout the study.

To learn more and see if you qualify, click here to take the next step.